Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$539M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$365M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$361M |
| 4 |
Charter Communications
CHTR
|
+$349M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.31B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$283M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$257M |
| 4 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$230M |
| 5 |
VanEck Oil Services ETF
OIH
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.94% |
| 2 | Healthcare | 5.53% |
| 3 | Financials | 5.03% |
| 4 | Consumer Discretionary | 4.6% |
| 5 | Industrials | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Columbia Sportswear
COLM
$3.25B
| $2.09M | ﹤0.01% |
31,011
+18,121
| +141% | +$1.33M |
|
2077
Itron
ITRI
$4.48B
| $2.08M | ﹤0.01% |
49,525
-11,071
| -18% | -$551K |
|
2078
Affiliated Managers Group
AMG
$9.51B
| $2.08M | ﹤0.01% |
18,635
+727
| +4% | +$91.2K |
|
2079
Bausch + Lomb
BLCO
$5.78B
| $2.08M | ﹤0.01% |
134,598
+128,850
| +2,242% | +$2.05M |
|
2080
RadNet
RDNT
$4.98B
| $2.08M | ﹤0.01% |
102,257
+3,971
| +4% | +$80K |
|
2081
Par Pacific Holdings
PARR
$4.17B
| $2.08M | ﹤0.01% |
126,598
-59,625
| -32% | -$1.01M |
|
2082
CALL
McDonald's
MCD
$193B
| $2.08M | ﹤0.01% |
9,000
-900
| -9% | -$230K |
|
2083
CALL
Amylyx Pharmaceuticals
AMLX
$2.19B
| $2.08M | ﹤0.01% |
+73,700
| New | +$1.84M |
|
2084
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.84B
| $2.07M | ﹤0.01% |
15,712
-911
| -5% | -$128K |
|
2085
Radware
RDWR
$983M
| $2.07M | ﹤0.01% |
95,070
+32,370
| +52% | +$722K |
|
2086
nCino
NCNO
$2.06B
| $2.07M | ﹤0.01% |
60,608
+38,200
| +170% | +$1.29M |
|
2087
Nutanix
NTNX
$16.1B
| $2.07M | ﹤0.01% |
99,163
-24,741
| -20% | -$451K |
|
2088
Compañía de Minas Buenaventura
BVN
$7.68B
| $2.06M | ﹤0.01% |
306,599
+143,812
| +88% | +$854K |
|
2089
Saic
SAIC
$4.95B
| $2.06M | ﹤0.01% |
23,298
-6,058
| -21% | -$564K |
|
2090
RBC Bearings
RBC
$17.4B
| $2.06M | ﹤0.01% |
9,906
-1,919
| -16% | -$442K |
|
2091
iShares Select U.S. REIT ETF
ICF
$2.13B
| $2.05M | ﹤0.01% |
38,205
-7,091
| -16% | -$441K |
|
2092
Coca-Cola Femsa
KOF
$22.8B
| $2.04M | ﹤0.01% |
35,011
+2,590
| +8% | +$154K |
|
2093
InterContinental Hotels
IHG
$23.8B
| $2.04M | ﹤0.01% |
42,031
-2,593
| -6% | -$146K |
|
2094
OmniAb
OABI
$283M
| $2.04M | ﹤0.01% |
+199,998
| New | +$2.03M |
|
2095
Imperial Oil
IMO
$62.3B
| $2.04M | ﹤0.01% |
46,845
-6,567
| -12% | -$300K |
|
|
IEA
2096
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $2.04M | ﹤0.01% |
150,287
+143,825
| +2,226% | +$1.87M |
|
2097
Leggett & Platt
LEG
$1.4B
| $2.03M | ﹤0.01% |
61,017
+18,198
| +42% | +$691K |
|
2098
CALL
Neurocrine Biosciences
NBIX
$18.2B
| $2.02M | ﹤0.01% |
19,000
+17,700
| +1,362% | +$1.8M |
|
|
2099
PUT
Neurocrine Biosciences
NBIX
$18.2B
| $2.02M | ﹤0.01% |
+19,000
| New | +$1.93M |
|
2100
Qfin Holdings
QFIN
$1.68B
| $2.02M | ﹤0.01% |
157,425
-346,817
| -69% | -$5.05M |
|
Similar funds
Citigroup's Q3 2022 Portfolio in Review
As of Q3 2022, Citigroup held 6,714 positions worth $140B, up 4% from $134B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup deployed $13.5B of net new capital in Q3 2022, opening 321 new positions and adding to 2,151 existing holdings. Its largest new stake was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.31B trimmed.
- Citigroup's largest Q3 2022 buy was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
- Citigroup added most to Lowe's Companies in Q3 2022, an estimated $539M increase.
- Citigroup's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.31B.
- Citigroup fully exited GCP Applied Technologies Inc. in Q3 2022, selling an estimated $18.7M.
- Citigroup's ten largest holdings make up 30% of its $140B portfolio in Q3 2022.
- Citigroup opened 321 new positions and closed 759 in Q3 2022.
- Citigroup's portfolio value rose 4% quarter-over-quarter to $140B.
Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.